SARS-CoV-2 Omicron is highly transmissible and has substantial resistance to antibody neutralization following immunization with ancestral spike-matched vaccines. It is unclear whether boosting with Omicron-specific vaccines would enhance immunity and protection. Here, nonhuman primates that received mRNA-1273 at weeks 0 and 4 were boosted at week 41 with mRNA-1273 or mRNA-Omicron. Neutralizing antibody titers against D614G were 4760 and 270 reciprocal ID50 at week 6 (peak) and week 41 (pre-boost), respectively, and 320 and 110 for Omicron. Two weeks after boost, titers against D614G and Omicron increased to 5360 and 2980, respectively, for mRNA-1273 and 2670 and 1930 for mRNA-Omicron. Following either boost, 70-80% of spike-specific B cells were cross-reactive against both WA1 and Omicron. Significant and equivalent control of virus replication in lower airways was observed following either boost. Therefore, an Omicron boost may not provide greater immunity or protection compared to a boost with the current mRNA-1273 vaccine.
www.biorxiv.org/content/10.1101/2022.02.03.479037v1
Omicron-specific booster may not be needed, US monkey study finds
“It means we don’t need to radically redesign the vaccine to make it an Omicron vaccine.”
Douek said he believes the reason is that both the original and the Omicron-specific vaccines are “cross-reactive,” meaning they can recognize lots of different variants.
www.thesentral.my/2022/02/05/omicron-specific-booster-may-not-be-needed-us-monkey-study-finds/
www.yahoo.com/now/omicron-specific-booster-may-not-230608960.html
www.tribuneindia.com/news/schools/omicron-specific-booster-may-not-be-needed-u-s-monkey-study-finds-367335
h/t PANDEMIC OF THE VACCINATED